Shenlian Biomedical to hold 2025 earnings briefing

Shenlian Biomedical announced that it will participate in the 2025 Annual Report Collective Performance Briefing for Listed Companies in Shanghai, while also holding its 2025 First Quarter Report Performance Briefing. The meeting is scheduled for May 15, 2025, from 15:00 to 16:30, and will be conducted online via the Shanghai Stock Exchange Roadshow Center. Investors can submit questions in advance via the Roadshow Center website or by emailing slsw@slbio.com.cn between May 8 and May 14. The company's management team, including Chairman Nie Dongsheng, General Manager Zhang Zhen, and CFO Li Xun, will address investor concerns regarding the 2024 annual report and the first quarter 2025 results during the interactive session. The announcement aims to facilitate a deeper understanding of the company's financial performance among investors.